|

Tacrolimus Extended Release Oral Tablet Clinical Trials

1 actively recruiting trial

Also known as: Envarsus

Pipeline

Phase 4: 1

Top Sponsors

  • University of British Columbia1

Indications

  • Tacrolimus1
  • Neurotoxicity1
  • Liver Disease1
  • Tremor1
  • Immunosuppression1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.